BACKGROUND: Multiple human papillomavirus (HPV) genotypes may be independently or synergistically associated with risk of high-grade squamous intraepithelial lesions (HSILs). We evaluated the risk of HSIL in women concomitantly infected with multiple HPV genotypes. METHODS: A population-based stratified sample of 59 664 cervical cytology specimens from women residing in New Mexico were evaluated for cytologic abnormalities and HPV genotypes. We calculated the risk of HSIL in women infected with a single HPV genotype and the risk in those infected with multiple HPV genotypes. RESULTS: The highest risk of HSIL was observed for HPV-16 (0.036), followed by HPV-33 (0.028), HPV-58 (0.024), and HPV-18 (0.022). For most types, we observed a greater risk of HSIL in women infected with multiple carcinogenic HPV types. In contrast, the risk of HSIL was similar in women infected with HPV-16 and other types, compared with women infected with HPV-16 only. We observed an increased but plateauing risk of HSIL in women infected with multiple types, compared with those infected with a single type, with risk ratios of 1.5 (95% confidence interval [CI], 1.2-1.8), 1.7 (95% CI, 1.3-2.4), and 1.4 (95% CI, 0.83-2.5) for women infected with 2, 3, and ≥4 genotypes, respectively. CONCLUSIONS: In the largest population-based study of HPV genotypes and cytologic outcomes so far, we did not see more than additive effects of HPV types on the risk of HSIL in women infected with multiple types.
BACKGROUND: Multiple human papillomavirus (HPV) genotypes may be independently or synergistically associated with risk of high-grade squamous intraepithelial lesions (HSILs). We evaluated the risk of HSIL in women concomitantly infected with multiple HPV genotypes. METHODS: A population-based stratified sample of 59 664 cervical cytology specimens from women residing in New Mexico were evaluated for cytologic abnormalities and HPV genotypes. We calculated the risk of HSIL in women infected with a single HPV genotype and the risk in those infected with multiple HPV genotypes. RESULTS: The highest risk of HSIL was observed for HPV-16 (0.036), followed by HPV-33 (0.028), HPV-58 (0.024), and HPV-18 (0.022). For most types, we observed a greater risk of HSIL in women infected with multiple carcinogenic HPV types. In contrast, the risk of HSIL was similar in women infected with HPV-16 and other types, compared with women infected with HPV-16 only. We observed an increased but plateauing risk of HSIL in women infected with multiple types, compared with those infected with a single type, with risk ratios of 1.5 (95% confidence interval [CI], 1.2-1.8), 1.7 (95% CI, 1.3-2.4), and 1.4 (95% CI, 0.83-2.5) for women infected with 2, 3, and ≥4 genotypes, respectively. CONCLUSIONS: In the largest population-based study of HPV genotypes and cytologic outcomes so far, we did not see more than additive effects of HPV types on the risk of HSIL in women infected with multiple types.
Entities:
Keywords:
cervical cancer screening; cytology; human papillomavirus (HPV); multiple Infections
Authors: Cosette M Wheeler; William C Hunt; Jack Cuzick; Erika Langsfeld; Amanda Pearse; George D Montoya; Michael Robertson; Catherine A Shearman; Philip E Castle Journal: Int J Cancer Date: 2012-06-20 Impact factor: 7.396
Authors: Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk Journal: Cancer Res Date: 2006-10-15 Impact factor: 12.701
Authors: Susanne Kjaer; Estrid Høgdall; Kirsten Frederiksen; Christian Munk; Adriaan van den Brule; Edith Svare; Chris Meijer; Attilla Lorincz; Thomas Iftner Journal: Cancer Res Date: 2006-10-23 Impact factor: 12.701
Authors: Helen Trottier; Salaheddin Mahmud; Maria Cecilia Costa; João P Sobrinho; Eliane Duarte-Franco; Thomas E Rohan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-07 Impact factor: 4.254
Authors: Mark Schiffman; Andrew G Glass; Nicolas Wentzensen; Brenda B Rush; Philip E Castle; David R Scott; Julie Buckland; Mark E Sherman; Greg Rydzak; Peter Kirk; Attila T Lorincz; Sholom Wacholder; Robert D Burk Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-05-20 Impact factor: 4.254
Authors: Jacolien van der Marel; Wim G V Quint; Mark Schiffman; Miekel M van de Sandt; Rosemary E Zuna; S Terence Dunn; Katherine Smith; Cara A Mathews; Michael A Gold; Joan Walker; Nicolas Wentzensen Journal: Int J Cancer Date: 2012-04-16 Impact factor: 7.396
Authors: Carolina Porras; Ana Cecilia Rodríguez; Allan Hildesheim; Rolando Herrero; Paula González; Sholom Wacholder; Robert D Burk; Mark Schiffman Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03 Impact factor: 4.254
Authors: Zhenping Shen; Xia Liu; Janice Morihara; Ayaka Hulbert; Laura A Koutsky; Nancy B Kiviat; Long Fu Xi Journal: Intervirology Date: 2016-01-28 Impact factor: 1.763
Authors: Brittney L Dickey; Anna E Coghill; Grant B Ellsworth; Timothy J Wilkin; Luisa L Villa; Anna R Giuliano Journal: Sex Transm Dis Date: 2021-12-01 Impact factor: 2.830
Authors: Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman Journal: BMC Cancer Date: 2015-06-23 Impact factor: 4.430
Authors: S Rachel Skinner; Cosette M Wheeler; Barbara Romanowski; Xavier Castellsagué; Eduardo Lazcano-Ponce; M Rowena Del Rosario-Raymundo; Carlos Vallejos; Galina Minkina; Daniel Pereira Da Silva; Shelly McNeil; Vera Prilepskaya; Irina Gogotadze; Deborah Money; Suzanne M Garland; Viktor Romanenko; Diane M Harper; Myron J Levin; Archana Chatterjee; Brecht Geeraerts; Frank Struyf; Gary Dubin; Marie-Cécile Bozonnat; Dominique Rosillon; Laurence Baril Journal: Int J Cancer Date: 2016-05-15 Impact factor: 7.396
Authors: Jazbet Gallegos-Bolaños; Jessica Alejandra Rivera-Domínguez; José Miguel Presno-Bernal; Rodolfo Daniel Cervantes-Villagrana Journal: BMC Cancer Date: 2017-08-08 Impact factor: 4.430
Authors: Jose Jeronimo; Philip E Castle; Sarah Temin; Lynette Denny; Vandana Gupta; Jane J Kim; Silvana Luciani; Daniel Murokora; Twalib Ngoma; Youlin Qiao; Michael Quinn; Rengaswamy Sankaranarayanan; Peter Sasieni; Kathleen M Schmeler; Surendra S Shastri Journal: J Glob Oncol Date: 2016-10-12